Original Research
Published on 15 Nov 2019
CPT1A/2-Mediated FAO Enhancement—A Metabolic Target in Radioresistant Breast Cancer
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2019.01201
- 17,223 views
- 154 citations
